Skip to main navigation
  • About Stoke
    • Leadership
  • Our Science
    • Tango
    • Publications
    • Founders
  • Disease Areas
    • Dravet Syndrome
    • ADOA
  • Pipeline
    • Clinical Studies
  • Careers
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
Stoke Therapeutics
  • Contact Us
  • LinkedIn
  • Twitter
  • About Stoke
    • Leadership
  • Our Science
    • Tango
    • Publications
    • Founders
  • Disease Areas
    • Dravet Syndrome
    • ADOA
  • Pipeline
    • Clinical Studies
  • Careers
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
  • Home
  • Investors & News
  • Financials & SEC Filings
  • SEC Filing Details

SEC Filing Details

Document Details

Form
8-K
Filing Date
March 15, 2023
Document Date
March 15, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Stoke Therapeutics
Issuer
Stoke Therapeutics, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Print Page
Email Alerts
Contact IR
Investor FAQs
  • About Us
  • Our Science
  • Disease Areas
  • Pipeline
  • Careers
  • Investors & News
  • Contact Us
Stoke Logo

© 2023 Stoke Therapeutics, all rights reserved.

  • Privacy Policy
  • Terms of Use
  • Site Map
  • LinkedIn
  • Twitter